Neogenomics (NEO) Interest Expenses (2011 - 2026)

Neogenomics has reported Interest Expenses for 13 years, with the latest figure at $598000.0 in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 63.04% year-over-year to $598000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (down 58.27% YoY), and the FY2025 full-year result was $3.8 million, down 43.28% from the prior year.
• Interest Expenses for Q1 2026 stood at $598000.0, roughly flat from $599000.0 in the prior quarter.
• The five-year high for Interest Expenses was $5.2 million in Q4 2022, with the low at $139000.0 in Q3 2022.
• Historically, Interest Expenses has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
• Annual changes were most pronounced in 2022 — Interest Expenses plunged 89.27% — and 2023, when it jumped 1112.23%.
• Neogenomics' Interest Expenses stood at $5.2 million in 2022, then plunged by 67.77% to $1.7 million in 2023, then retreated by 3.39% to $1.6 million in 2024, then tumbled by 63.12% to $599000.0 in 2025, then dropped by 0.17% to $598000.0 in 2026.
• The last three Interest Expenses figures came in at $598000.0 (Q1 2026), $599000.0 (Q4 2025), and $603000.0 (Q3 2025), per Business Quant data.